Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › prurigo nodularis

Prurigo nodularis

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for prurigo nodularis

16 trials tracked for prurigo nodularis: 10 in phase 3 or 4 and 2 with published results. The most-cited published study has 158 citations.

16Trials tracked
10Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 9 Phase 2 6
  1. Phase 3 A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) Completed · 158 cited
  2. Phase 3 Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) Completed · 158 cited
  3. Phase 4 Pain Outcomes Following Intralesional Corticosteroid Injections Completed
  4. Phase 3 A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis Completed
  5. Phase 3 PRISM Study-Pruritus Relief Through Itch Scratch Modulation Completed
  6. Phase 3 A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) Completed
Show 10 more trials
  1. Phase 3 Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Completed
  2. Phase 3 Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis Completed
  3. Phase 3 Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis Completed
  4. Phase 3 Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Completed
  5. Phase 2 Safety and Efficacy of CC-10004 for Prurigo Nodularis Completed
  6. Phase 2 A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN) Completed
  7. Phase 2 A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis Completed
  8. Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis Completed
  9. Phase 2 Safety and Efficacy of Nemolizumab in PN Completed
  10. Phase 2 Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.